Has Gloria Huang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $27,173 in general payments to Gloria Huang, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gloria Huang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gloria Huang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gloria Huang, MD

Gynecologic Oncology · New Haven, CTNPI 1497835961

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $24,163 of the $27,173 with a category attached, or 88.9%. 8 manufacturers reported payments, led by GSK at 38.7% of the total. Reporting peaked in 2019 at $11,847 and has fallen 99.8% since, to $28 in 2024. Among gynecologic oncology clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,173in general payments, 2019–2025

Across 33 payments — averaging $823.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$11K
E.r. Squibb & Sons, L.L.C.$7K
Tesaro, Inc.$6K
AstraZeneca$4K
Foundation Medicine, Inc.$170
Immunogen, Inc.$76
plus $41 from 2 others

What the payments were for

Consulting fees$24,16389%
Grants$5962%
Travel & lodging$1,5726%
Food & beverage$7813%
Education$610%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	2	$10,513
E.r. Squibb & Sons, L.L.C.	9	$6,509
Tesaro, Inc.	16	$5,843
AstraZeneca	2	$4,021
Foundation Medicine, Inc.	1	$170
Immunogen, Inc.	1	$76
Regeneron	1	$28
Collegium Pharmaceutical, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,173 in reported general payments places this provider in the 95th percentile of 25 gynecologic oncology providers in Connecticut.

See all gynecologic oncology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$3,220

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in New Haven

Mitchell ClarkNew Haven$9K
Blair McNamaraNew Haven$1K
Aparna KailasamNew Haven$1K
Peter SchwartzNew Haven$614
Masoud AzodiNew Haven$519
Katyayani PapatlaNew Haven$270
Gulden MenderesBridgeport$35K
Karen NishidaStamford$26K
Amy BrownHartford$23K
Xun ZhouNew Britain$5K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →